Navinta Llc, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Apothecon- Your trusted partner for APIs & HPAPIs// Emerging leader in therapeutic generic drugs.
One of their notable products is SODIUM NITROPRUSSIDE USP, with a corresponding US DMF Number 31164.
Remarkably, this DMF maintains an Active status since its submission on June 02, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 05, 2017, and payment made on June 01, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II